Title : Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.

Pub. Date : 2014 Oct 7

PMID : 25289898






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prostaglandin E2 stimulates beta1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-kappaB pathway. Dinoprostone nuclear factor kappa B subunit 1 Homo sapiens
2 17-PT-PGE2 treatment induced PKC and NF-kappaB activation; PKC and NF-kappaB inhibitors suppressed 17-PT-PGE2-mediated beta1-integrin expression. Dinoprostone nuclear factor kappa B subunit 1 Homo sapiens
3 17-PT-PGE2 treatment induced PKC and NF-kappaB activation; PKC and NF-kappaB inhibitors suppressed 17-PT-PGE2-mediated beta1-integrin expression. Dinoprostone nuclear factor kappa B subunit 1 Homo sapiens
4 NF-kappaB inhibitor suppressed 17-PT-PGE2-mediated FoxC2 upregulation. Dinoprostone nuclear factor kappa B subunit 1 Homo sapiens
5 This study suggested that PGE2 upregulates beta1-integrin expression and cell migration in HCC cells by activating the PKC/NF-kappaB signaling pathway. Dinoprostone nuclear factor kappa B subunit 1 Homo sapiens
6 Targeting PGE2/EP1/PKC/NF-kappaB/FoxC2/beta1-integrin pathway may represent a new therapeutic strategy for the prevention and treatment of this cancer. Dinoprostone nuclear factor kappa B subunit 1 Homo sapiens